Literature DB >> 11688961

High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice.

N Kitamura1, T Iwamura, S Taniguchi, H Yamanari, M A Kawano, K Hollingsworth, T Setoguchi.   

Abstract

Cell lines with high metastatic capacity to the lung were established by sequential passage of a human pancreatic cancer cell line (SUIT-2) through the lung of a nude mouse, via the lateral tail vein and from a subcutaneous inoculum. Cells of the parental SUIT-2 and sublines S2-VPx (x-cycle selection from SUIT-2 cells, by Vein-Pulmonary metastasis-culture) and S2-CPx (x-cycle selection, by Cutis-Pulmonary metastasis-culture) were injected intravenously or subcutaneously into nude mice to produce experimental or spontaneous lung metastasis. The S2-VP10 cell line produced pulmonary metastases in 100% of the nude mice, when injected intravenously. It failed, however, to produce more lung colonies than its parent cell line, when injected subcutaneously. The S2-CP8 cell line produced extensive pulmonary metastases in 100% of the nude mice, when injected either intravenously or subcutaneously. This study indicates that the nude mouse provided a good model for in vivo selection of metastatic cells from SUIT-2 cells both experimentally and spontaneously, and that the SUIT-2, S2-VPx, and S2-CPx cell lines will be valuable in the study of human cancer metastasis. We previously reported high levels of ezrin expression in the S2-VP10 and S2-CP8 cell lines. Here we show that these cell lines exhibit a greater capacity to invade or attach to various extracellular matrix components than the parent SUIT-2 cells. The S2-CP8 cell lines also exhibit greater level of type-I and type-IV collagen-degrading activity than the parent SUIT-2 cell line and the S2-VP10 cell line, which shows similar collagen-degrading activity to the parent SUIT-2 cells. In RT-PCR studies, SUIT-2, S2-CP8 and S2-VP10 cell lines constitutively expressed many matrix metalloproteinases (MMP-1, MMP-2, MMP-3, MMP7, MMP-9, MMP-10 and MMP-14). These results suggest that some parameters that enhance adhesion and invasion are important to both experimental and spontaneous metastasis and the collagen degrading enzymes are predicted to play a key-role during spontaneous metastasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11688961     DOI: 10.1023/a:1011900818419

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  59 in total

1.  Heterogeneities of attachment, chemotaxis, and protease production among clones with different metastatic potentials from a human pancreatic cancer cell line.

Authors:  S Taniguchi; T Iwamura; N Kitamura; H Yamanari; T Setoguchi
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

2.  Cell culture characterization: monitoring for cell identification.

Authors:  W D Peterson; W F Simpson; B Hukku
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

3.  High-malignancy orthotopic nude mouse model of human prostate cancer LNCaP.

Authors:  X Wang; Z An; J Geller; R M Hoffman
Journal:  Prostate       Date:  1999-05-15       Impact factor: 4.104

4.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

5.  Cancer metastasis is selective or random depending on the parent tumour population.

Authors:  J E Talmadge; I J Fidler
Journal:  Nature       Date:  1982-06-17       Impact factor: 49.962

6.  Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue.

Authors:  T Furukawa; X Fu; T Kubota; M Watanabe; M Kitajima; R M Hoffman
Journal:  Cancer Res       Date:  1993-03-01       Impact factor: 12.701

7.  Metastatic model of human colon cancer constructed using orthotopic implantation in nude mice.

Authors:  Y Ogata; Y Hara; Y Akagi; A Ohkita; T Morodomi; K Shirouzu
Journal:  Kurume Med J       Date:  1998

8.  Characterization of the tumorigenic and metastatic properties of a human pancreatic tumor cell line (AsPC-1) implanted orthotopically into nude mice.

Authors:  M H Tan; T M Chu
Journal:  Tumour Biol       Date:  1985

9.  ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons.

Authors:  S Tsukita; K Oishi; N Sato; J Sagara; A Kawai; S Tsukita
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

10.  Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2.

Authors:  S Yonemura; M Hirao; Y Doi; N Takahashi; T Kondo; S Tsukita; S Tsukita
Journal:  J Cell Biol       Date:  1998-02-23       Impact factor: 10.539

View more
  10 in total

1.  KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model.

Authors:  Lacey R McNally; Danny R Welch; Benjamin H Beck; Lewis J Stafford; Joshua W Long; Jeffery C Sellers; Zhi Q Huang; William E Grizzle; Cecil R Stockard; Kevin T Nash; Donald J Buchsbaum
Journal:  Clin Exp Metastasis       Date:  2010-09-16       Impact factor: 5.150

2.  Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer.

Authors:  Julius Chapiro; Surojit Sur; Lynn Jeanette Savic; Shanmugasundaram Ganapathy-Kanniappan; Juvenal Reyes; Rafael Duran; Sivarajan Chettiar Thiruganasambandam; Cassandra Rae Moats; MingDe Lin; Weibo Luo; Phuoc T Tran; Joseph M Herman; Gregg L Semenza; Andrew J Ewald; Bert Vogelstein; Jean-François Geschwind
Journal:  Clin Cancer Res       Date:  2014-10-17       Impact factor: 12.531

3.  RHOA and PRKCZ control different aspects of cell motility in pancreatic cancer metastatic clones.

Authors:  Marco Della Peruta; Cinzia Giagulli; Carlo Laudanna; Aldo Scarpa; Claudio Sorio
Journal:  Mol Cancer       Date:  2010-03-17       Impact factor: 27.401

4.  Sulindac treatment alters collagen and matrilysin expression in adenomas of ApcMin/+ mice.

Authors:  Hector Guillen-Ahlers; Steven A Buechler; Mark A Suckow; Francis J Castellino; Victoria A Ploplis
Journal:  Carcinogenesis       Date:  2008-05-21       Impact factor: 4.944

5.  ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage.

Authors:  Asmi Chakraborty; Kaitlyn A Dorsett; Hoa Q Trummell; Eddy S Yang; Patsy G Oliver; James A Bonner; Donald J Buchsbaum; Susan L Bellis
Journal:  J Biol Chem       Date:  2017-11-30       Impact factor: 5.157

6.  Ezrin promotes invasion and metastasis of pancreatic cancer cells.

Authors:  Yunxiao Meng; Zhaohui Lu; Shuangni Yu; Qiang Zhang; Yihui Ma; Jie Chen
Journal:  J Transl Med       Date:  2010-06-23       Impact factor: 5.531

7.  Detection of Phosphatidylcholine-Coated Gold Nanoparticles in Orthotopic Pancreatic Adenocarcinoma using Hyperspectral Imaging.

Authors:  Christopher G England; Justin S Huang; Kurtis T James; Guandong Zhang; André M Gobin; Hermann B Frieboes
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

8.  Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.

Authors:  Jingjia Ye; Makiko Kawaguchi; Yukihiro Haruyama; Ai Kanemaru; Tsuyoshi Fukushima; Koji Yamamoto; Chen-Yong Lin; Hiroaki Kataoka
Journal:  Cancer Sci       Date:  2013-11-25       Impact factor: 6.716

Review 9.  From bench to cageside: Risk assessment for rodent pathogen contamination of cells and biologics.

Authors:  Norman C Peterson
Journal:  ILAR J       Date:  2008

10.  Endostatin expression in pancreatic tissue is modulated by elastase.

Authors:  R D Brammer; S R Bramhall; M C Eggo
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.